Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration

被引：41

作者：

Tara M. Breslin

Kenneth R. Hess

Dana B. Harbison

Marina E. Jean

Karen R. Cleary

Alan P. Dackiw

Robert A. Wolff

James L. Abbruzzese

Nora A. Janjan

Christopher H. Crane

J. Nicolas Vauthey

Jeffrey E. Lee

Peter W. T. Pisters

Douglas B. Evans

机构：

[1] The University of Texas M. D. Anderson Cancer Center,Department of Surgical Oncology

[2] The University of Texas M. D. Anderson Cancer Center,Department of Biostatistics

[3] The University of Texas M. D. Anderson Cancer Center,Department of Pathology

[4] The University of Texas M. D. Anderson Cancer Center,Department of Gastrointestinal Oncology

[5] The University of Texas M. D. Anderson Cancer Center,Department of Radiation Oncology

[6] UT M. D. Anderson Cancer Center,Department of Surgical Oncology

来源：

Annals of Surgical Oncology | 2001年 / 8卷 / 2期

关键词：

Pancreaticoduodenectomy; Pancreatic cancer; Chemoradiation;

D O I：

10.1007/s10434-001-0123-4

中图分类号：

学科分类号：

摘要：

Background:For patients with potentially resectable pancreatic cancer, the poor outcome associated with resection alone and the survival advantage demonstrated for combined-modality therapy have stimulated interest in preoperative chemoradiotherapy. The goal of this study was to analyze the effects of different preoperative chemoradiotherapy schedules, intraoperative radiation therapy, patient factors, and histopathologic variables on survival duration and patterns of treatment failure in patients who underwent pancreaticoduodenectomy for adenocarcinoma of the pancreatic head.

引用

页码：123 / 132

页数：9

共 82 条

[1]

Kalser MH(1987)Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer Cancer 59 2006-10

[2]

Ellenberg SS(1985)Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120 899-903

[3]

Yeo CJ(1997)Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience Ann Surg 225 621-633

[4]

Abrams RA(1999)Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC Gastrointestinal Tract Cooperative Group Ann Surg 230 776-782

[5]

Grochow LB(2000)ESPAC-1 interim results: a European, randomized study to assess the roles of adjuvant chemotherapy (5FU+folinic acid) and adjuvant chemoradiation (40 Gy+5FU) in resectable pancreatic cancer Proc Am Soc clin Oncol 19 238(abstract)-24;

[6]

Klinkenbijl JH(1996)Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head Am J Surg 171 118-489

[7]

Jeekel J(1993)Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ±5-fluorouracil Int J Radiat Oncol Biol Phys 26 483-323

[8]

Sahmoud T(1998)Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group J Clin Oncol 16 317-1143

[9]

Neoptlemos J(1991)Adjuvant therapy of resected adenocarcinoma of the pancreas Int J Radiat Oncol Biol Phys 21 1137-937

[10]

Dunn J(1997)Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas J Clin Oncol 15 928-1339

← 1 2 3 4 5 6 7 8 9 →